Form D · Biotechnology
MenoGeniX, Inc.
Aurora, CO · CIK 0001555128
Offering snapshot reported Dec 14, 2017 · SEC filing
- Reported sold
- $75K Offering amount: $200K
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 30, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2017 | Initial | $75,000 | No comparison | 4 | SEC filing |
| Sep 2, 2016 | Initial | $200,000 | No comparison | 14 | SEC filing |
| Aug 8, 2014 | Initial | $405,000 | No comparison | 15 | SEC filing |
| Jul 31, 2012 | Initial | $500,000 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300751
Promissory notes convertible into equity securities of the Issuer
Source: Form D, filed Dec 14, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Debra M. Duke | Executive |
| Richard C. Duke | Director, Executive |
| James Woodruff Emlen | Director |
| T. Richard Fort | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12635 East Montview Blvd., Suite 100
Aurora, CO, 80045
Aurora, CO, 80045